Format

Send to

Choose Destination
Lancet Oncol. 2016 Nov;17(11):1464-1465. doi: 10.1016/S1470-2045(16)30524-1.

Diminished but not dead: chemotherapy for the treatment of NSCLC.

Author information

1
Section of Medical Oncology, Yale Cancer Center, New Haven, CT 06520-8028, US. Electronic address: roy.herbst@yale.edu.
2
Section of Medical Oncology, Yale Cancer Center, New Haven, CT 06520-8028, US.
PMID:
27819227
DOI:
10.1016/S1470-2045(16)30524-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center